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ABSTRACT  
Ischemia/reperfusion (I/R) injury is a severe inflammatory insult associated with numerous 
pathologies such as myocardial infarction, stroke and acute kidney injury. I/R injury is 
characterized by a rapid influx of activated neutrophils secreting toxic free radical species 
and degrading enzymes that can irreversibly damage the tissue, thus impairing organ 
functions. Significant efforts have been invested in identifying therapeutic targets to 
suppress neutrophil recruitment and activation post I/R injury. In this context, 
pharmacological targeting of neutrophil elastase (NE) has shown promising anti-
inflammatory efficacy in a number of experimental and clinical settings of I/R injury, and 
is considered a plausible clinical strategy for organ care. However, the mechanisms of 
action of NE, and hence its inhibitors, in this process is not fully understood. Here we 
conducted a comprehensive analysis of the impact of NE genetic deletion on neutrophil 
infiltration in four murine models of I/R injury as induced in the heart, kidneys, intestine 
and cremaster muscle. In all models, neutrophil migration into ischemic regions was 
significantly suppressed in NE-/- mice as compared to wild-type controls. Analysis of 
inflamed cremaster muscle and mesenteric microvessels by intravital and confocal 
microscopy revealed a selective entrapment of neutrophils within venular walls, most 
notably at the level of the venular basement membrane (BM) following NE-
deletion/pharmacological blockade. This effect was associated with the suppression of 
NE-mediated remodeling of the low matrix protein expressing regions within the venular 
BM used by transmigrating neutrophils as exit portals. Furthermore, whilst NE deficiency 
led to reduced neutrophil activation and vascular leakage, levels of monocytes and pro-
healing M2 macrophages were reduced in tissues of NE-/- mice subjected to I/R. 
Collectively our results identify a vital and non-redundant role for NE in supporting 
neutrophil breaching of the venular BM post I/R injury but also suggest a protective role 
for NE in promoting tissue repair.  
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INTRODUCTION 
Ischemia/reperfusion (I/R) injury is a common feature of many cardiovascular pathologies 
such as myocardial infarction, cerebral stroke and clinical complications associated with 
organ transplantation surgeries [1-4]. The occurrence of I/R injury is paradoxical in that it 
is induced following the often life-saving process of restoration of blood flow to ischemic 
tissues. Whilst this practice is aimed at providing nutrients and oxygen to affected regions, 
and hence preventing tissue necrosis, the procedure can lead to vascular dysfunction [5], 
acute inflammation and ultimately increase in tissue-cell death [6]. This pathophysiological 
response is largely the consequence of a rapid activation of the vascular endothelium and 
an intense recruitment of pro-inflammatory leukocytes [7].   
Neutrophils are the first leukocytes to be recruited to sites of I/R injury. These innate 
immune cells, whilst vital for host defense against pathogens are implicated in the 
pathogenesis of many disorders due to their capacity to release a wide range of pro-
inflammatory mediators [8,9], reactive oxygen species [10] and destructive proteolytic 
enzymes. Clear evidence for the involvement of neutrophils in I/R injury has been provided 
by both preclinical and clinical studies in which neutrophil depletion was protective against 
further tissue damage [11-14]. Similarly, blocking neutrophil interaction with blood vessel 
walls within reperfused areas of ischemic tissues improves disease outcome in patients 
[15-17]. However, the inhibitors used in such settings are not solely specific for neutrophil 
recruitment and also blocked the migration of other leukocyte sub-types, including 
monocytes that can contribute to tissue healing. As such, there remains a need for 
alternative therapeutic approaches for suppressing neutrophil migration and their 
destructive potential following I/R injury. 
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Neutrophil Elastase (NE) is the most abundant protease expressed by neutrophils [18,19] 
and that is rapidly released from azurophilic granules upon activation. This serine protease 
can act on a broad range of substrates including extracellular matrix components, pro-
enzymes, adhesion molecules, signaling receptors and cytokines [20,21]. It also has 
strong antibacterial properties and is implicated in NETosis [22]. Due to this wide-ranging 
substrate specificity and function, NE has been implicated in numerous physiological and 
pathological scenarios including I/R injury [23]; and is considered as a good indicator of 
disease severity in respiratory and cardiovascular pathologies [24,25]. Interestingly, 
natural and synthetic NE blockers inhibit I/R-induced inflammation in both pre-clinical and 
clinical studies [26]. In sharp contrast, NE-deficient animals (NE-/-) showed normal 
neutrophil recruitment in experimental models of cytokine-induced inflammation [27] and 
bacterial infection [28,29]. Taken together, such conflicting studies suggest a stimulus-
specific role for NE as a regulator of neutrophil trafficking, and importantly highlight the 
lack of understanding of the mechanisms through which NE regulates neutrophil migration 
and possibly activation.  
 
The aim of the present study was to re-evaluate the potential strength of NE as a 
therapeutic target for suppression of I/R-induced inflammation and to ascertain its 
mechanism of action in mediating neutrophil trafficking post I/R injury. We hypothesized 
that during I/R injury, NE is rapidly induced on the cell surface of transmigrating 
neutrophils, and as such plays a unique and non-redundant role in facilitating neutrophil 
migration through blood venular walls. For this purpose, we investigated the role of NE 
using both NE-deficient mice and a well-characterized NE inhibitor (ONO-5046, sivelestat) 
[30], in multiple disease-mimicking murine models of I/R injury, including models of 
myocardial and renal I/R injury; and have ascertained the site of arrest of neutrophils at 
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the level of the venular basement membrane under conditions of NE deletion/blockade 
during I/R injury. Mechanistically, the function of NE was linked to its mobilization from 
transmigrating neutrophils within the venular basement membrane (BM) and its ability to 
remodel neutrophil permissive regions within the venular BM termed low expression 
regions (LERs). Overall, the present findings provide unequivocal evidence for an 
essential role for NE in neutrophil migration through venular walls in I/R injury, identifying 
the breaching of the venular BM as a key NE-mediated stage of neutrophil trafficking 
during this pathology.  
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MATERIALS AND METHODS 
Detailed materials and methods are available in supplementary material, Supplementary 
Materials and methods. 
 
Animals 
NE knock-out (NE-/-) male mice and C57BL/6 wild-type (WT) animals were employed. All 
animal experiments were conducted in accordance with the United Kingdom Home Office 
legislation and NC3R recommendations. 
 
Treatments 
Anaesthetized WT mice were injected via jugular vein cannulation with saline or with 
sivelestat (ONO-5046) with an initial dose of 50 mg/kg in a 200 μl bolus followed by an 
infusion of 50 mg/kg at 200 μl per hour.  
 
Ischemia/reperfusion injury of the heart: 
Anaesthetized animals were subjected to myocardial infarction by ligation of the left 
anterior descending coronary artery for 25 min, followed by a reperfusion period of 2 h. 
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Ischemia/reperfusion injury of the kidneys: 
Anaesthetized animals were subjected to bilateral renal ischemia for 30 min followed by 
a 24 h reperfusion period.  
 
Intravital microscopy and induction of cremasteric ischemia/reperfusion injury 
The cremaster muscle was surgically exteriorized and subjected to ischemia using an 
artery clamp placed at the proximal end of the cremaster tissue for 30 min. Blood flow was 
then restored by releasing the clamp and reperfusion was allowed to develop for up to 2 
h. Leukocyte responses (adhesion and extravasation) were observed on an upright bright-
field microscope.  
 
Intravital microscopy and induction of ischemia/reperfusion injury of the mesenteric tissue 
Mesenteric ischemia was induced by clamping the superior mesenteric artery for 35 min 
before allowing the reperfusion of the tissue for 90 min. Leukocyte responses (adhesion 
and extravasation) were quantified within mesenteric post-capillary venules.  
 
Determination of renal injury and dysfunction 
Histological evaluation was performed on kidney sections stained with hematoxylin and 
eosin, and viewed using a bright-field microscope. The serum levels of creatinine and 
aspartate aminotransferase were quantified by ELISA.  
 
9 
 
Adoptive cell transfer experiments 
Bone marrow leukocytes from WT or NE-/- donor mice were fluorescently labeled with 
PKH26 according to the manufacturer’s recommendations and injected intravenously into 
WT or NE-/- recipient animals via the tail vein prior to I/R injury of the cremaster muscles 
as detailed above. At the end of the reperfusion period, the harvested tissues were 
immunostained for confocal microscopy analysis. Blood samples were also taken by 
cardiac puncture, and the number of circulating PKH26+ cells was analyzed by flow 
cytometry.  
 
Analysis of tissues by immunofluorescence labeling and confocal microscopy: 
Detection of neutrophils into the ischemic region of the heart was performed on OCT-
embedded heart tissue sections immunostained for collagen IV, endothelial cells and 
neutrophils. For localization of neutrophils into the cremaster muscles and mesenteric 
tissue following I/R injury, whole-mount tissues were fluorescently immunostained for 
neutrophils, the endothelium and the perivascular BM. For NE expression, tissues were 
fluorescently immunostained for neutrophils, NE and the perivascular BM. For NE activity, 
the NE-fluorescent activatable substrate NE680FAST (Perkin Elmer, Beaconsfield, UK) 
was injected i.v. prior to reperfusion. All samples were viewed using laser-scanning 
confocal microscopes and images were analyzed using IMARIS software. The area and 
intensity of matrix protein “Low expression regions” (LERs) within the perivascular 
basement membrane were measured using ImageJ (NIH & Laboratory for Optical and 
Computational Instrumentation, University of Wisconsin, USA). 
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Vascular leakage 
Vascular leakage upon I/R injury was quantified using the Miles assay [31].  
 
Flow cytometry analysis of leukocyte subpopulation 
Leukocyte subpopulations (neutrophils, monocytes and macrophages) present in the 
cremaster muscles and their phenotype were assessed by flow cytometry 20 h post I/R 
injury. 
 
Statistical analyses 
All data were processed and analyzed using GraphPad Prism 6 software (GraphPad Inc, 
San Diego, CA, USA), and are presented as mean  SEM. Statistical significance was 
assessed by parametric or non-parametric tests according to the sample size of the data 
analyzed. P < 0.05 taken as statistically significant.  
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RESULTS 
 
NE-deficient mice exhibit reduced neutrophil infiltration in models of myocardial 
and kidney ischemia reperfusion injury 
To ascertain the role of NE in neutrophil recruitment in clinically relevant models of I/R 
injury, we investigated the impact of genetic deletion of NE in murine models of myocardial 
and kidney I/R injury. With respect to the heart injury model, WT and NE-/- animals were 
subjected to myocardial infarction (MI) for 25 min followed by 2 h of reperfusion. The 
degree of tissue injury (depicted by increased anti-collagen mAb immunoreactivity) and 
levels of neutrophil infiltration into the heart ischemic region were investigated by confocal 
microscopy. WT mice subjected to MI exhibited an intense remodeling of the myocardial 
tissue, as illustrated by increased collagen-IV immunoreactivity in the ischemic area 
(Figure 1A,B), a response that was associated with a significant infiltration of neutrophils 
specifically in this region (Figure 1C) as compared to sham-operated WT mice (Figure 
1D,E). In contrast, NE-/- animals subjected to MI exhibited a similar morphology and levels 
of collagen IV immune-reactivity to that seen in sham-operated animals (Figure 1A,B). 
Interestingly, NE-/- mice exhibited no increase in local neutrophil infiltration post MI as 
compared to WT animals (Figure 1D,E).  
To ascertain the generality of the protective effect of NE genetic deficiency against I/R 
injury and neutrophil infiltration, we next investigated a model of renal I/R injury. Here, 
mice were subjected to bi-lateral renal ischemia for 30 min followed by reperfusion for 24 
h before collecting kidney and blood samples to assess the extent of local tissue damage, 
leukocyte infiltration and the loss of renal functions post I/R. Histological examination of 
WT kidneys subjected to I/R showed evidence of renal injury as exemplified by the 
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degeneration of proximal and distal tubules, tubular swelling and necrosis, and luminal 
congestion, as compared to sham-operated animals (Figure 2A,B). This response was 
also associated with increased PMN infiltration (Figure 2C, Supplementary material, 
Figure S1A). In contrast, NE-/- animals subjected to renal I/R showed almost normal 
kidney structure organization and an ~80% reduction in leukocyte infiltration. Analysis of 
sera from WT mice subjected to renal I/R showed a significant increase in markers of renal 
dysfunction/injury, namely high levels of creatinine and aspartate aminotransferase, as 
compared to levels detected in serum of both sham-operated WT mice and NE-/- animals 
subjected to kidney I/R  (Supplementary material, Figure 1B,C).  
Collectively these results demonstrate that NE deficiency is protective in both models of 
MI and renal I/R injury, an effect that involved a marked inhibition of the acute neutrophil 
recruitment to locally injured tissues. 
 
NE deficiency inhibits I/R-induced neutrophil migration into tissues by selectively 
suppressing breaching of venular walls at the level of the basement membrane  
To gain insight into the mechanism through which NE mediates I/R-induced neutrophil 
recruitment, we sought to determine the stage of the emigration cascade at which NE 
acts. For this purpose, we first applied intravital microscopy (IVM) to the analysis of 
leukocyte responses within cremasteric venules of WT and NE–/– mice subjected to local 
I/R injury, as previously described [32,33]. Within this I/R model, robust and time-
dependent leukocyte adhesion and transmigration responses were noted within the 2 h 
reperfusion period in WT mice, as compared to sham-operated animals (Figure 3A, 
Supplementary material, Movies S1, S2). Interestingly, neutrophil emigration into 
inflamed tissues was almost completely inhibited in NE-/- animals (94% inhibition) whilst 
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leukocyte adhesion was unaffected (Figure 3A). Of note, the percentage of blood 
circulating neutrophils and key microvascular flow hemodynamic parameters were the 
same between WT and NE-/- mice (Supplementary material, Figure S2). Pre-treatment 
of WT animals with silvestat also resulted in an inhibition of leukocyte extravasation but 
not adhesion (Supplementary material, Figure 3A,B). Similar results were obtained in a 
model of mesenteric I/R where NE-/- mice showed no defect in leukocyte adhesion but 
were profoundly suppressed in terms of leukocyte extravasation into interstitial tissues as 
compared to WT animals (Figure 3B, Supplementary material Figure S2, Movie S3).  
To ascertain if the role of NE is mediating neutrophil breaching of venular walls is driven 
by a cell-autonomous mechanism involving neutrophil-derived NE (as opposed to tissue-
derived NE), we conducted a series of cell transfer experiments in which fluorescently-
labeled bone-marrow leukocytes derived from WT and NE-/- mice were injected 
intravenously into WT or NE-/- recipient animals prior to I/R injury. At the end of the 
reperfusion period, the transmigration response of donor leukocytes in cremaster muscles 
was analyzed by confocal microscopy. Donor WT leukocytes showed similar profile of 
transmigration post I/R injury when injected in WT or NE-/- recipient animals, suggesting 
that the genetic background of the recipient mouse (i.e. NE deficiency in the vasculature 
and interstitial tissue) does not account for the defective neutrophil transmigration 
response noted in NE-/- animals (Figure 3C). However, when NE-/- leukocytes were 
transferred into WT or NE-/- recipient animals, the migration of these donor cells into 
tissues was significantly suppressed, indicating that the role of NE in the migration of 
neutrophils through the vessel wall in I/R injury is a cell-autonomous effect.  
As breaching the venular wall involves penetrating multiple barriers, including the 
endothelium and the venular BM [34,35], we next determined the site of arrest of NE-
deficient neutrophils within venular walls in whole-mount immunostained tissues using 
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confocal microscopy. The images showed a significant increase in the number of 
neutrophils that had breached the endothelium but were retained within the venular wall 
in NE-/- mice as compared to WT controls post reperfusion period (Figure 3D,E). Similar 
results were obtained in the model of mesenteric I/R (Figure 3F). WT mice pre-treated 
with the NE inhibitor sivelestat and subjected to cremasteric I/R also showed increased 
number of neutrophils within the venular wall post breaching of the endothelium, as 
compared to mice treated with the drug vehicle (Supplementary material, Figure S3C).  
Collectively these results identify a selective role for neutrophil-derived NE in mediating 
leukocyte migration through venular walls, a response that appears to occur in a cell-
autonomous manner. Furthermore, whilst NE deletion or pharmacological blockade does 
not impact neutrophil transendothelial migration, NE appears to play an important role in 
neutrophil breaching of the venular basement membrane post I/R injury. 
 
Neutrophil-derived NE is retained within the venular BM during neutrophil 
transmigration. 
Having found that NE deficiency leads to neutrophil retention at the level of the venular 
BM in a cell-autonomous manner, we aimed to gain more insight into the mechanism 
through which this happens. Initially, we determined the localization of NE enzymatic 
activity and protein expression during the process of neutrophil migration from the 
vascular lumen into the interstitial space as assessed by immunostaining and analysis of 
tissues by confocal microscopy. Using a specific NE-fluorescent activatable substrate 
(NE680FAST) injected i.v., we observed an intense NE activity associated with neutrophils 
located in the abluminal aspect of the vessel wall (i.e. within the venular BM), and at a 
lower level in tissue infiltrated leukocytes (Figure 4A). Similarly, using a specific antibody 
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(Supplementary material, Figure S4), NE was strongly associated with neutrophils 
within both the vascular lumen and the venular wall, and, to a lesser extent, in tissue-
infiltrated neutrophils (Figure 3B,C). Quantification of neutrophil NE expression at 
different stages of neutrophil migration through the venular wall demonstrated a significant 
decrease in the neutrophil-associated NE as the cells moved from the vascular lumen to 
the interstitial tissue. Specifically, neutrophils within the venular BM and interstitial tissues 
post I/R injury showed 33.6% and 57.0% reduction in NE expression, as compared to 
luminal neutrophils, respectively. Interestingly, this response was associated with an 
increase in NE localization within the BM itself in WT mice subjected to I/R injury but not 
in NE-/- animals (Figure 3D).  
Taken together, these results suggest that during I/R injury, neutrophils release 
approximately one third of their NE content within the venular BM as they encounter this 
structure during their emigration into the interstitium.  
 
NE mediates remodeling of the venular BM  
We have previously reported on the expression and remodeling of regions within the 
venular BM that exhibit reduced levels of certain matrix proteins (e.g. collagen IV and 
laminins) that act as preferred exit portals for transmigrating neutrophils [36,37]. These 
regions, termed matrix protein low expression regions (LERs), were investigated here in 
terms of their size by confocal microscopy in cremasteric and mesenteric tissues post I/R 
injury. Whilst WT mice subjected to I/R showed increased average size of venular BM 
LERs as compared to sham-treated mice, no such increase was noted in NE-/- animals 
(Figure 5A–D). Pharmacological blockade of NE also suppressed the increase in size of 
LERs in the cremaster muscle I/R injury model (Supplementary material, Figure S3D). 
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Interestingly, immunostaining of WT tissues with antibodies against neutrophils and 
venular BM (pan-laminin Ab), demonstrated that ~30% and 50% of tissue infiltrated 
neutrophils were immunoreactive for laminin in the cremaster muscle and mesenteric I/R 
models, respectively (Figure 5E,F), suggesting carriage of laminin fragments by migrating 
neutrophils.  
Taken together these results demonstrate that NE can facilitate remodeling of the venular 
BM through increasing the size of neutrophil permissive regions. This remodeling likely 
occurs through disruption of the laminin network of the BM, as mediated via cleavage and 
carriage of laminin fragments by the emigrating neutrophils.    
 
NE-/- mice exhibit reduced I/R-induced neutrophil activation and vascular leakage, 
but also show suppressed recruitment of monocytes and pro-healing M2-
macrophages in inflamed tissues.  
In a final series of experiments we investigated the potential impact of NE deletion on 
other key cellular features of I/R injury, namely neutrophil activation, vascular leakage and 
recruitment of monocytes. The activation state of tissue infiltrated neutrophils (both in the 
interstitium and vasculature, Figure 6A) in sham and I/R injured cremaster muscles of WT 
and NE-deficient mice was quantified through analyzing levels of reactive oxygen species 
(ROS) by flow cytometry. Whilst neutrophils present in WT cremaster muscles exhibited 
an enhanced DHE signal (Figure 6B) (and higher CD11b expression, MFI = 21732±4389 
versus 14276±1335 for I/R versus sham-operated group, respectively) as compared to 
cells in sham-operated tissues or blood leukocytes, the few neutrophils found in NE-/- 
tissues (mainly within the vasculature and the venular wall (Figure 3 and Figure 6A) had 
a reduced DHE signal (Figure 6A,B). The suppressed activation state of NE-/- tissue 
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neutrophils was associated with reduced vascular leakage in the KO mice post I/R injury, 
as compared to the response noted in WT animals (Figure 6C). Interestingly however, in 
assessing the impact of NE deficiency on the resolution phase of the I/R injury, whilst both 
monocyte and M2 macrophage numbers were elevated in WT cremaster muscles at 20 h 
post-reperfusion (Figure 6D,E), these responses were markedly inhibited in NE-/- animals. 
Of note, local I/R insult had no impact on blood monocyte numbers in either WT on NE-/- 
animals (supplementary material, Figure S5). 
Collectively, these results suggest that although blocking NE-dependent neutrophil 
extravasation may be an effective strategy at reducing the number and activation state of 
tissue infiltrated neutrophils, such an intervention may also affect the recruitment of tissue 
healing immune cells such as monocytes and M2 macrophages.  
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DISCUSSION 
 
The migration of neutrophils from the blood stream into inflamed tissues is a tightly 
regulated process essential for the rapid development of an effective immune response 
against injury and invading pathogens. This phenomenon, extensively studied during 
physiological responses in healthy tissues [34,35,38], is also a key element in the 
development of many acute and life-threatening inflammatory pathologies [39,40] such as 
I/R injury [11-13,15]. Several therapeutic strategies have been tested both in pre-clinical 
and clinical studies of inflammatory conditions to inhibit neutrophil recruitment and/or 
functions through the use of natural or synthetic (e.g. sivelestat) inhibitors of NE [26,41]. 
The use of sivelestat in particular confirmed the potential of targeting NE for the treatment 
of disorders such as acute lung injury [42], complications arising from myocardial surgery 
[43], organ transplantation [44] and several model of ischemia reperfusion injury [45-47]. 
However, at present the specific role(s) of NE in I/R injury remains poorly understood. To 
address this issue, here we have comprehensively studied the role of NE in neutrophil 
migration in multiple murine models of I/R injury using both genetic deletion and 
pharmacological inhibition. Our findings provide univocal evidence for a vital and non-
redundant role for NE in mediating neutrophil tissue infiltration post I/R and categorically 
identify breaching and remodeling of the venular BM as a key site of action of NE in this 
process. However, our results also indicate that suppressing NE can lead to reduced 
tissue infiltration of wound healing immune cells, highlighting a need for better 
understanding of the mechanisms of actions of NE inhibitors.  
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Early studies suggested that NE was a key candidate for the regulation of neutrophil 
recruitment at sites of I/R injury, though such works failed to fully establish the associated 
mechanisms [48]. NE can potentially impact the migration of neutrophils through blood 
vessel walls at multiple levels. For example, NE can cleave cell-adhesion (e.g. ICAM-1) 
[49] and junctional (e.g. JAM-C) [50] molecules present on the endothelium, pro-
inflammatory cell surface receptors (e.g. TLR4, PAR-2) [51,52], and components of the 
venular BM (e.g. elastin, laminins) [53]. NE can also regulate the bioactivity and/or 
bioavailability of numerous pro-inflammatory cytokines (TNF) and chemokines (IL-8) 
[54,55]. Here we studied NE in the context of I/R injury as induced in the myocardium, 
kidneys, mesentery and cremaster muscles. In all models, a dramatic suppression of 
tissue-infiltration of neutrophils was noted, with some indications of concomitant inhibition 
of acute tissue injury. Similar results were obtained using an NE inhibitor, observations 
that are in agreement with previously published works using different models of I/R injury 
[45-47] and confirming the efficacy of sivelestat in the treatment of perioperative acute 
inflammatory responses in the clinic [42,43]. In sharp contrast, the use of NE-deficient 
mice have led to conflicting and varied results regarding the functions of this protease in 
neutrophil infiltration, questioning the efficacy and specificity of existing NE inhibitors. 
Several reports have shown that NE-/- mice can exhibit a normal neutrophil transmigration 
response in models of bacterial infections [29] or in reductive experimental models of 
tissue inflammation as induced by bacterial derived products (LPS), cytokines (TNF, IL-
1β) [27],[36], or neutrophil-chemoattractants (LTB4) [56]. Such conflicting results may 
suggest the existence of compensatory mechanisms in NE-/- mice as mediated via the 
actions of other serine proteases (e.g. PR3) with similar functions to that noted with NE. 
In support of such a possibility we have previously shown that a broad-spectrum serine 
protease inhibitor can suppress IL-1β-induced neutrophil transmigration in both WT and 
NE-/- mice [56]. Divergent impacts of NE deficiency could also be attributed to differing 
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mechanisms of action of NE in distinct inflammatory scenarios. For example, the 
suppression of neutrophil recruitment in NE-deficient mice within a zymozan-induced 
peritonitis model was aligned with reduced generation of the pro-inflammatory 
chemokines CXCL1 and CCL3 [27]. Of note, within the cremaster muscle I/R model 
employed here, whilst significant suppression of neutrophil recruitment was observed in 
NE-/- animals, this was not mediated through reduced levels of endogenous chemokines 
(e.g. CXCL1 or CCL2; data not shown). Overall, considering the broad substrate 
specificity of NE, and the wide range of stimuli that can induce its release and/or cell 
surface expression on neutrophils, it is not inconceivable that NE shows different functions 
and efficacy in regulating neutrophil trafficking as governed by the nature and severity of 
the inflammatory trigger. 
 
To investigate what stage of neutrophil trafficking NE supported post I/R, we analyzed the 
dynamics of neutrophil responses in I/R injured cremaster muscles and mesenteric tissues 
of WT and NE-/- mice by intravital microscopy. These studies identified a selective role for 
NE in mediating neutrophil breaching of venular walls. Interestingly, adoptive transfer of 
neutrophils deficient in NE into WT mice led to suppression of neutrophil migration, 
providing direct evidence for the ability of neutrophil-derived NE in supporting neutrophil 
trafficking in a cell autonomous manner. In addition to proteases, previous studies have 
shown that neutrophil-derived LTB4 can act in a feed-forward manner to support a 
collective directional motility phenomenon within interstitial tissues known as swarming 
[57]. As well as providing chemotactic cues, cell autonomous pathways can regulate 
neutrophil polarity and migration, such as that reported for neutrophil-derived ATP and its 
hydrolyzed form, adenosine [58], and neutrophil-expressed junctional adhesion molecule-
A (JAM-A) [59].  
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Having identified breaching of venular walls as the site of arrest of NE-deficient 
neutrophils, detailed analysis of I/R injured tissues indicated that NE-/- neutrophils were 
unable to penetrate the vascular basement membrane. The latter is a critical step in 
neutrophil breaching of the venular wall and subsequent migration into the interstitial 
tissue [35]. Disruption of venular basement membrane following neutrophil transmigration 
was first demonstrated in vitro [60], though the associated mechanisms remained elusive 
for many years. Significant insight to this phase of neutrophil trafficking was provided by 
our previous works where we identified regions within the venular BM that exhibit lower 
deposition of certain matrix proteins, such as collagen IV and laminins [36,37]. 
Functionally, these regions are the preferred sites of neutrophil egress through the venular 
BM, and are remodeled by transmigrating neutrophils in terms of their size and protein 
content upon cytokine and chemokine-induced inflammation in a strictly neutrophil-
dependent manner [36,37]. These specialized venular wall regions termed matrix protein 
low expression regions (LERs) are now accepted as a key element of neutrophil trafficking 
[61-63]. In the current study we noted that NE-mediated neutrophil migration through 
venular walls involves remodeling of the LERs. These findings are supported by in vitro 
studies showing that NE can cleave extracellular matrix proteins such as laminin [53] and 
collagen [64]. In mediating breaching of the venular BM, it is plausible to consider that NE 
achieves this through localized expression on the cell surface of migrating neutrophils. 
Indeed, NE can be expressed at the cell surface of neutrophils upon stimulation [56] 
through its binding to negatively-charged glyocoproteins [65] or via its interaction with the 
leukocyte integrin MAC-1 [50,66]. In the present study, the use of an NE-specific 
fluorescent activatable substrate indicated the association of NE activity with neutrophils 
within the abluminal aspect of the vessel wall of cremaster muscles. These findings 
support the concept that membrane-bound NE is critical in facilitating NE-mediated 
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functions as it renders the enzyme resistant to endogenous inhibition[67]. Another 
example of this is the role of NE in supporting the aberrant mode of neutrophil 
transendothelial migration (TEM), neutrophil reverse TEM, i.e. movement within 
endothelial cell junctions in an abluminal to luminal direction [68]. This junctional reverse 
motility response of neutrophils was most pronounced following I/R injury [68] and was 
mechanistically linked with NE-mediated cleavage of the endothelial cell tight junctional 
molecule JAM-C via its binding to neutrophil Mac-1 in vivo [50]. In the present study, we 
observed that in addition to be being cell surface expressed, NE was also released within 
the venular BM during neutrophil extravasation. Interestingly, the remodeling of LERs in 
the cremaster muscle and mesenteric I/R injury models was associated with the presence 
of a subpopulation of tissue-infiltrated neutrophils that were immunostained for laminin. 
Collectively these results suggest that neutrophils can remodel the venular BM LERs 
through localized cell surface expression of NE and/or localized release of NE within the 
venular BM. The former could lead to neutrophils carrying fragments of venular BM 
laminin, possibly via their cell surface expression of laminin-binding receptor α6β1 
integrin, as we have previously described [69,70]. 
Having found that functional blockade of NE retains neutrophils within venular walls in I/R-
stimulated tissues, and considering the relevance of these findings to future therapeutic 
use of NE blockers, we sought to investigate if such a vascular retention phenomena could 
have detrimental vascular/tissue effects. In addressing this notion, the activation state of 
tissue infiltrated neutrophils and vascular permeability in WT and NE-/- mice was 
quantified. These studies showed reduced neutrophil activation, as measured through 
ROS generation, and vascular leakage in NE-/- mice, suggesting that retention of 
potentially activated neutrophils within the venular wall does not impede vascular barrier 
integrity. However, in assessing the resolution phase of I/R injury, we noted that NE-
genetic deficiency was associated with reduced recruitment of monocytes and M2 
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macrophages. These findings are in line with the notion that neutrophil diapedesis can 
mediate monocyte migration [71,72] and can promote macrophage polarization towards 
a pro-healing phenotype [73].  
Collectively, our findings demonstrate a selective and non-redundant role for NE in I/R-
induced neutrophil migration through venular walls as mediated via the remodeling of the 
venular BM. However, whilst the results suggest that NE inhibitors maybe useful strategies 
in suppressing acute neutrophil-mediated tissue damage post I/R, the findings also raise 
caution for the use of such drugs as blockade of neutrophil migration may compromise 
the tissue repair process via inhibiting recruitment of pro-healing immune cells. 
 
  
24 
 
ACKNOWLEDGMENTS 
The authors would like to thank Professor S Shapiro for providing the NE-deficient mice, 
Dr Nancy Hogg for providing the anti-mouse MRP-14 mAb and Dr Matthew Golding for 
his helpful assessment with the manuscript. 
 
FUNDING 
This work was supported by grants from the British Heart Foundation: PG/03/123/16102 
(SN and M-B V), FS/11/19/28761 (WA) and FS/05/078/19406 (LG and PM), the Wellcome 
Trust: 098291/Z/12/Z and 101604/Z/13/Z (SN), and Arthritis Research UK: 19913 (M-B 
V). 
 
Author contributions statement 
M-B V designed and performed most experiments, analyzed data, and contributed to the 
writing of the manuscript; GL designed and performed the myocardial I/R experiments and 
mesenteric I/R IVM; AW designed and performed the cremaster muscle I/R IVM; LL 
assisted with image acquisition and analysis of myocardial I/R experiment; NP, RDP and 
SC designed and performed the mesenteric I/R experiments and data analysis; SN 
provided overall project supervision, contributed to the design of experiments and the 
writing of the manuscript. 
  
25 
 
REFERENCES 
1. Chen F, Date H. Update on ischemia-reperfusion injury in lung transplantation. Curr 
Opin Organ Transplant 2015; 20: 515-520. 
2. Ferrari R, Balla C, Malagu M, et al. Reperfusion Damage- A Story of Success, 
Failure, and Hope. Circ J 2017; 81: 131-141. 
3. Mizuma A, Yenari MA. Anti-Inflammatory Targets for the Treatment of Reperfusion 
Injury in Stroke. Front Neurol 2017; 8: 467. 
4. Salvadori M, Rosso G, Bertoni E. Update on ischemia-reperfusion injury in kidney 
transplantation: Pathogenesis and treatment. World J Transplant 2015; 5: 52-67. 
5. Granger DN, Kvietys PR. Reperfusion therapy-What's with the obstructed, leaky 
and broken capillaries? Pathophysiology 2017; 24: 213-228. 
6. Eltzschig HK, Eckle T. Ischemia and reperfusion--from mechanism to translation. 
Nat Med 2011; 17: 1391-1401. 
7. Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory Disequilibrium 
in Stroke. Circ Res 2016; 119: 142-158. 
8. Tecchio C, Cassatella MA. Neutrophil-derived chemokines on the road to immunity. 
Semin Immunol 2016; 28: 119-128. 
9. Tecchio C, Micheletti A, Cassatella MA. Neutrophil-derived cytokines: facts beyond 
expression. Front Immunol 2014; 5: 508. 
10. Winterbourn CC, Kettle AJ, Hampton MB. Reactive Oxygen Species and Neutrophil 
Function. Annu Rev Biochem 2016; 85: 765-792. 
11. Albadawi H, Oklu R, Raacke Malley RE, et al. Effect of DNase I treatment and 
neutrophil depletion on acute limb ischemia-reperfusion injury in mice. J Vasc Surg 
2016; 64: 484-493. 
12. Garcia-Prieto J, Villena-Gutierrez R, Gomez M, et al. Neutrophil stunning by 
metoprolol reduces infarct size. Nat Commun 2017; 8: 14780. 
26 
 
13. Klausner JM, Paterson IS, Goldman G, et al. Postischemic renal injury is mediated 
by neutrophils and leukotrienes. Am J Physiol 1989; 256: F794-802. 
14. Sawa Y, Matsuda H. Myocardial protection with leukocyte depletion in cardiac 
surgery. Semin Thorac Cardiovasc Surg 2001; 13: 73-81. 
15. Wang K, Wen S, Jiao J, et al. IL-21 promotes myocardial ischaemia/reperfusion 
injury through the modulation of neutrophil infiltration. Br J Pharmacol 2017. 
16. Rabb H, Mendiola CC, Dietz J, et al. Role of CD11a and CD11b in ischemic acute 
renal failure in rats. Am J Physiol 1994; 267: F1052-1058. 
17. Kelly KJ, Williams WW, Jr., Colvin RB, et al. Intercellular adhesion molecule-1-
deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97: 
1056-1063. 
18. Hager M, Cowland JB, Borregaard N. Neutrophil granules in health and disease. J 
Intern Med 2010; 268: 25-34. 
19. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in 
inflammation. Microbes Infect 2003; 5: 1317-1327. 
20. Lee WL, Downey GP. Leukocyte elastase: physiological functions and role in acute 
lung injury. Am J Respir Crit Care Med 2001; 164: 896-904. 
21. Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev 
Immunol 2006; 6: 541-550. 
22. Papayannopoulos V, Metzler KD, Hakkim A, et al. Neutrophil elastase and 
myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 
2010; 191: 677-691. 
23. Vila N, Elena M, Deulofeu R, et al. Polymorphonuclear leukocyte elastase in 
patients with stroke. Acta Neurol Scand 1999; 100: 391-394. 
27 
 
24. Shapiro SD, Ingenito EP. The pathogenesis of chronic obstructive pulmonary 
disease: advances in the past 100 years. Am J Respir Cell Mol Biol 2005; 32: 367-
372. 
25. Smith FB, Fowkes FG, Rumley A, et al. Tissue plasminogen activator and 
leucocyte elastase as predictors of cardiovascular events in subjects with angina 
pectoris: Edinburgh Artery Study. Eur Heart J 2000; 21: 1607-1613. 
26. Henriksen PA. The potential of neutrophil elastase inhibitors as anti-inflammatory 
therapies. Curr Opin Hematol 2014; 21: 23-28. 
27. Young RE, Thompson RD, Larbi KY, et al. Neutrophil elastase (NE)-deficient mice 
demonstrate a nonredundant role for NE in neutrophil migration, generation of 
proinflammatory mediators, and phagocytosis in response to zymosan particles in 
vivo. J Immunol 2004; 172: 4493-4502. 
28. Belaaouaj A, McCarthy R, Baumann M, et al. Mice lacking neutrophil elastase 
reveal impaired host defense against gram negative bacterial sepsis. Nat Med 
1998; 4: 615-618. 
29. Hirche TO, Atkinson JJ, Bahr S, et al. Deficiency in neutrophil elastase does not 
impair neutrophil recruitment to inflamed sites. Am J Respir Cell Mol Biol 2004; 30: 
576-584. 
30. Kawabata K, Suzuki M, Sugitani M, et al. ONO-5046, a novel inhibitor of human 
neutrophil elastase. Biochem Biophys Res Commun 1991; 177: 814-820. 
31. Miles AA, Miles EM. Vascular reactions to histamine, histamine-liberator and 
leukotaxine in the skin of guinea-pigs. J Physiol 1952; 118: 228-257. 
32. Thompson RD, Noble KE, Larbi KY, et al. Platelet-endothelial cell adhesion 
molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-
specific role for PECAM-1 in leukocyte migration through the perivascular 
basement membrane. Blood 2001; 97: 1854-1860. 
28 
 
33. Woodfin A, Reichel CA, Khandoga A, et al. JAM-A mediates neutrophil 
transmigration in a stimulus-specific manner in vivo: evidence for sequential roles 
for JAM-A and PECAM-1 in neutrophil transmigration. Blood 2007; 110: 1848-1856. 
34. Nourshargh S, Hordijk PL, Sixt M. Breaching multiple barriers: leukocyte motility 
through venular walls and the interstitium. Nat Rev Mol Cell Biol 2010; 11: 366-378. 
35. Voisin MB, Nourshargh S. Neutrophil transmigration: emergence of an adhesive 
cascade within venular walls. J Innate Immun 2013; 5: 336-347. 
36. Wang S, Voisin MB, Larbi KY, et al. Venular basement membranes contain specific 
matrix protein low expression regions that act as exit points for emigrating 
neutrophils. J Exp Med 2006; 203: 1519-1532. 
37. Voisin MB, Probstl D, Nourshargh S. Venular basement membranes ubiquitously 
express matrix protein low-expression regions: characterization in multiple tissues 
and remodeling during inflammation. Am J Pathol 2010; 176: 482-495. 
38. Nourshargh S, Alon R. Leukocyte migration into inflamed tissues. Immunity 2014; 
41: 694-707. 
39. van der Linden M, Meyaard L. Fine-tuning neutrophil activation: Strategies and 
consequences. Immunol Lett 2016; 178: 3-9. 
40. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and 
inflammation. Nat Rev Immunol 2013; 13: 159-175. 
41. Williams SE, Brown TI, Roghanian A, et al. SLPI and elafin: one glove, many 
fingers. Clin Sci (Lond) 2006; 110: 21-35. 
42. Nomura N, Asano M, Saito T, et al. Sivelestat attenuates lung injury in surgery for 
congenital heart disease with pulmonary hypertension. Ann Thorac Surg 2013; 96: 
2184-2191. 
29 
 
43. Inoue N, Oka N, Kitamura T, et al. Neutrophil elastase inhibitor sivelestat 
attenuates perioperative inflammatory response in pediatric heart surgery with 
cardiopulmonary bypass. Int Heart J 2013; 54: 149-153. 
44. Harada M, Oto T, Otani S, et al. A neutrophil elastase inhibitor improves lung 
function during ex vivo lung perfusion. Gen Thorac Cardiovasc Surg 2015; 63: 645-
651. 
45. Uchida Y, Freitas MC, Zhao D, et al. The protective function of neutrophil elastase 
inhibitor in liver ischemia/reperfusion injury. Transplantation 2010; 89: 1050-1056. 
46. Fujimura N, Obara H, Suda K, et al. Neutrophil elastase inhibitor improves survival 
rate after ischemia reperfusion injury caused by supravisceral aortic clamping in 
rats. J Surg Res 2013; 180: e31-36. 
47. Sakai S, Tajima H, Miyashita T, et al. Sivelestat sodium hydrate inhibits neutrophil 
migration to the vessel wall and suppresses hepatic ischemia-reperfusion injury. 
Dig Dis Sci 2014; 59: 787-794. 
48. Zimmerman BJ, Granger DN. Reperfusion-induced leukocyte infiltration: role of 
elastase. Am J Physiol 1990; 259: H390-394. 
49. Champagne B, Tremblay P, Cantin A, et al. Proteolytic cleavage of ICAM-1 by 
human neutrophil elastase. J Immunol 1998; 161: 6398-6405. 
50. Colom B, Bodkin JV, Beyrau M, et al. Leukotriene B4-Neutrophil Elastase Axis 
Drives Neutrophil Reverse Transendothelial Cell Migration In Vivo. Immunity 2015; 
42: 1075-1086. 
51. Devaney JM, Greene CM, Taggart CC, et al. Neutrophil elastase up-regulates 
interleukin-8 via toll-like receptor 4. FEBS Lett 2003; 544: 129-132. 
52. Muley MM, Reid AR, Botz B, et al. Neutrophil elastase induces inflammation and 
pain in mouse knee joints via activation of proteinase-activated receptor-2. Br J 
Pharmacol 2016; 173: 766-777. 
30 
 
53. Mydel P, Shipley JM, Adair-Kirk TL, et al. Neutrophil elastase cleaves laminin-332 
(laminin-5) generating peptides that are chemotactic for neutrophils. J Biol Chem 
2008; 283: 9513-9522. 
54. Walsh DE, Greene CM, Carroll TP, et al. Interleukin-8 up-regulation by neutrophil 
elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium. J Biol 
Chem 2001; 276: 35494-35499. 
55. Benabid R, Wartelle J, Malleret L, et al. Neutrophil elastase modulates cytokine 
expression: contribution to host defense against Pseudomonas aeruginosa-
induced pneumonia. J Biol Chem 2012; 287: 34883-34894. 
56. Young RE, Voisin MB, Wang S, et al. Role of neutrophil elastase in LTB4-induced 
neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil 
elastase deficient mice. Br J Pharmacol 2007; 151: 628-637. 
57. Lammermann T, Afonso PV, Angermann BR, et al. Neutrophil swarms require 
LTB4 and integrins at sites of cell death in vivo. Nature 2013; 498: 371-375. 
58. Chen Y, Corriden R, Inoue Y, et al. ATP release guides neutrophil chemotaxis via 
P2Y2 and A3 receptors. Science 2006; 314: 1792-1795. 
59. Cera MR, Fabbri M, Molendini C, et al. JAM-A promotes neutrophil chemotaxis by 
controlling integrin internalization and recycling. J Cell Sci 2009; 122: 268-277. 
60. Huber AR, Weiss SJ. Disruption of the subendothelial basement membrane during 
neutrophil diapedesis in an in vitro construct of a blood vessel wall. J Clin Invest 
1989; 83: 1122-1136. 
61. Poduval P, Sillat T, Virtanen I, et al. Abnormal basement membrane type IV 
collagen alpha-chain composition in labial salivary glands in Sjogren's syndrome. 
Arthritis Rheum 2009; 60: 938-945. 
31 
 
62. Reichel CA, Rehberg M, Bihari P, et al. Gelatinases mediate neutrophil recruitment 
in vivo: evidence for stimulus specificity and a critical role in collagen IV remodeling. 
J Leukoc Biol 2008; 83: 864-874. 
63. Reichel CA, Rehberg M, Lerchenberger M, et al. Ccl2 and Ccl3 mediate neutrophil 
recruitment via induction of protein synthesis and generation of lipid mediators. 
Arterioscler Thromb Vasc Biol 2009; 29: 1787-1793. 
64. Weathington NM, van Houwelingen AH, Noerager BD, et al. A novel peptide CXCR 
ligand derived from extracellular matrix degradation during airway inflammation. 
Nat Med 2006; 12: 317-323. 
65. Campbell EJ, Owen CA. The sulfate groups of chondroitin sulfate- and heparan 
sulfate-containing proteoglycans in neutrophil plasma membranes are novel 
binding sites for human leukocyte elastase and cathepsin G. J Biol Chem 2007; 
282: 14645-14654. 
66. Cai TQ, Wright SD. Human leukocyte elastase is an endogenous ligand for the 
integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates 
polymorphonuclear leukocyte adhesion. J Exp Med 1996; 184: 1213-1223. 
67. Owen CA, Campbell MA, Sannes PL, et al. Cell surface-bound elastase and 
cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which 
neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol 
1995; 131: 775-789. 
68. Woodfin A, Voisin MB, Beyrau M, et al. The junctional adhesion molecule JAM-C 
regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol 
2011; 12: 761-769. 
69. Dangerfield JP, Wang S, Nourshargh S. Blockade of alpha6 integrin inhibits IL-
1beta- but not TNF-alpha-induced neutrophil transmigration in vivo. J Leukoc Biol 
2005; 77: 159-165. 
32 
 
70. Wang S, Dangerfield JP, Young RE, et al. PECAM-1, alpha6 integrins and 
neutrophil elastase cooperate in mediating neutrophil transmigration. J Cell Sci 
2005; 118: 2067-2076. 
71. Soehnlein O, Zernecke A, Eriksson EE, et al. Neutrophil secretion products pave 
the way for inflammatory monocytes. Blood 2008; 112: 1461-1471. 
72. Wantha S, Alard JE, Megens RT, et al. Neutrophil-derived cathelicidin promotes 
adhesion of classical monocytes. Circ Res 2013; 112: 792-801. 
73. Horckmans M, Ring L, Duchene J, et al. Neutrophils orchestrate post-myocardial 
infarction healing by polarizing macrophages towards a reparative phenotype. Eur 
Heart J 2017; 38: 187-197. 
*74.  Hobbs JA, May R, Tanousis K, et al. Myeloid cell function in MRP-14 (S100A9) null 
mice. Mol Cell Biol 2003; 23: 2564-2576. 
*75.  Brines M, Patel NS, Villa P, et al. Nonerythropoietic, tissue-protective peptides 
derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A 2008; 
105: 10925-10930. 
*76.  Patel NS, Cuzzocrea S, Chatterjee PK, et al. Reduction of renal ischemia-
reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase 
inhibitor zileuton. Mol Pharmacol 2004; 66: 220-227. 
*77. Voisin MB, Woodfin A, Nourshargh S. Monocytes and neutrophils exhibit both distinct 
and common mechanisms in penetrating the vascular basement membrane in vivo. 
Arterioscler Thromb Vasc Biol 2009; 29: 1193-1199. 
 
 
 
* Cited only in supplementary material. 
  
33 
 
FIGURE LEGENDS 
 
Figure 1. Neutrophil recruitment into the area at risk of neutrophil elastase deficient 
mice is impaired following myocardial infarction and reperfusion injury. 
(A) Reconstructed tiling images of myocardial cryosections acquired by confocal 
microscopy from wildtype (WT) animals and neutrophil elastase deficient mice (NE-/-) and 
subjected to 25 min of myocardial infarction followed by 2 h of reperfusion (I/R). Tissue 
sections from sham-operated WT (left panels), I/R-subjected WT (middle panels) and I/R-
subjected NE-/- (right panels) animals were immunostained for collagen type IV (red). The 
yellow box exemplify the ischemic and reperfused region of the left ventricle (area at risk). 
(B) Quantification of the Collagen type IV mean intensity in area at risk (yellow box from 
(A)). (C) Confocal images of the area at risk (delimited by the dotted line) from a WT 
animal subjected to myocardial I/R and immunostained for collagen type IV (red), PECAM-
1 (blue) and MRP-14 (green) to visualize the extracellular cellular matrix, blood 
vasculature and neutrophils, respectively. The image shows neutrophils infiltrating the 
region at risk only. (D)  Magnified regions of the region of left ventricle subjected or not to 
I/R from WT (top panels) and NE-/- (bottom panels) animals. Cryosections were 
immunostained for collagen type IV (red), PECAM-1 (blue) and MRP-14 (green) to 
visualize the extracellular cellular matrix, blood vasculature and neutrophils, respectively. 
Left panels show the three channels together whilst the right panels show the neutrophil 
channel only. The images exemplify the absence of neutrophil infiltration in the region at 
risk of the myocardium from NE-/- mice subjected to I/R as compared to WT littermates. 
The top right panels (WT I/R) are magnified images of the same sample region as shown 
in (D). (E) Quantification of the number of neutrophils present in the area at risk. Data 
represent mean ± SEM from 3 or 4 mice per group. **P<0.01 and *** P<0.001 for 
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comparison between I/R versus sham-operated animals; and # P<0.05, ### P<0.001 for 
comparison between WT and NE-/- mice as indicated by lines. Scale bars = 100 µm.                                         
 
 
Figure 2. Neutrophil elastase deficient mice are protected from renal ischemia and 
reperfusion injury. 
(A) Histopathology of kidney sections from sham-operated WT or WT and NE-/- mouse 
subjected to renal ischemia/reperfusion and stained with hematoxylin and eosin. The 
bottom pictures are magnified regions (yellow box) demonstrating the modification of the 
architectural structure of tubules and glomeruli upon I/R injury in WT but not NE-/- animals. 
(B) Histological score analysis of kidney sections. (C) Quantification of the number of PMN 
infiltrating the kidney. Data represent mean ± SEM from at least 4 animals per group. *** 
P<0.001 for comparison between I/R versus sham-operated animals; and ### P<0.001 
for comparison between WT and NE-/- mice as indicated by lines. Scale bar = 100 µm. 
 
 
Figure 3. Effect of neutrophil elastase deficiency on leukocyte transmigration 
responses in post-capillary venules in vivo following ischemia/reperfusion injury.  
Leukocyte’s firm adhesion and transmigration in post-capillary venules of mouse 
cremaster muscles or mesentery in response to I/R were investigated using intravital 
microscopy. (A) The mouse cremaster muscle from WT and NE-/- animals was surgically 
exteriorized, superfused with Tyrode's solution and basal leukocyte responses were 
quantified for 20 min prior to the induction of ischemia using a clamp as detailed in 
Materials and methods. Thirty minutes later, the clamp on the exteriorized cremaster 
muscle was removed to induce the reperfusion of the vessels. Leukocyte adhesion (left 
panel) and extravasation (right panel) responses were quantified at regular intervals for 
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120 min post reperfusion. For each genotype, a sham-operated group was also analyzed 
(exteriorized cremaster tissues without the clamp). (B) WT and NE-/- mice were subjected 
to occlusion of the superior mesenteric artery for 35 min, followed by 90 min reperfusion. 
For each genotype, a sham-treatment group was also analyzed, where laparotomy was 
conducted without the occlusion of the mesenteric arteries. Both leukocyte adhesion (left 
panel) and transmigration (right panel) responses were quantified in post-capillary venules 
at 90 min post-reperfusion. (C) Bone marrow neutrophils were isolated from WT or NE-/- 
mice, fluorescently labeled and injected intravenously into WT or NE−/− recipient mice 
prior to the induction of ischemia and reperfusion of the cremaster muscle as detailed in 
Materials and methods. At the end of the experiment, tissues where harvested, fixed and 
immunostained for neutrophils (MRP-14), Data show the quantification of fluorescent 
donor neutrophils present in the tissue and normalized to the number of blood circulating 
donor cells. (D) The images are representative confocal pictures of post-capillary venules 
of the cremaster muscles of WT (left panel) and NE-/- (right panel) mice subjected to 30 
min of ischemia followed by 120 min of reperfusion of the cremaster muscles. The images 
show that whilst in WT neutrophils access the interstitial tissue, NE−/− cells are trapped 
within the venular basement membrane (arrows). (E) Quantification of the number of 
neutrophils present within the venular basement membrane 2 h post-reperfusion of the 
cremaster muscles. (F) Quantification of the number of neutrophils present within the 
venular basement membrane following 1.5 h post-reperfusion of the mesentery. Figures 
are representative of 4–7 animals per group. Mean ± SEM. * P<0.05, ** P<0.01, *** 
P<0.001 for comparison between I/R versus sham-operated animals (or between WT and 
NE-/- donor cells for the adoptive transfer experiment); and # P<0.05, ## P<0.01, ### 
P<0.001 for comparison between WT and NE-/- mice as indicated by lines. Bars = 20µm. 
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Figure 4. NE is mobilized during the migration of neutrophils through the venular 
basement membrane. 
The cremaster muscles and mesentery of WT and NE−/− mice were subjected to temporary 
ischemia followed by reperfusion. At the end of the reperfusion period, tissues were 
collected, fixed and immunostained prior to visualization of the samples using confocal 
microscopy. (A) Representative image of a post-capillary venule (CD31, red) of WT and 
NE-/- animals subjected to I/R injury and demonstrating the association of the enzymatic 
activity of NE using the NE680FAST fluorescent substrate (blue) with neutrophils (green) 
present in the abluminal aspect (i.e. BM) of the vessel wall (plain arrows), and at a lesser 
extent, interstitial neutrophils (dotted arrows). (B) Representative confocal image of a 
post-capillary venule (2 µm longitudinal cross-section from the middle of the vessel, green) 
from a WT mouse subjected to I/R showing NE expression (red) in the cytoplasmic 
compartments (blue) of neutrophils. The bottom panels are enlargements of the yellow 
boxed region showing neutrophils at different stages of their migration route: i.e. luminal 
(i), within the vascular basement membrane (ii) or within the interstitial tissue (iii). A 5% 
opacity filter on the MRP14 channel was applied to highlight NE expression in neutrophils 
on the right panel. (C) Quantification of the mean fluorescence intensity of NE expression 
in neutrophils at the three stages of their migration (as expressed as percentage change 
over the intensity of NE from luminal neutrophils). (D) Quantification of the fluorescence 
intensity of NE expression within the venular basement membrane form WT and NE-/- 
animals at 1 h post-reperfusion. Figures are representative of 4–7 animals per group.  
Mean ± SEM. * P<0.05, ** P<0.01, *** P<0.001, for comparison of the NE intensity (MFI) 
between BM/interstitial neutrophils versus luminal cells (C), or between I/R versus sham-
operated animals (D); and # P<0.05, ## P<0.01 for comparison between WT and NE-/- 
mice as indicated by the line. Bars = 10µm. 
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Figure 5. Venular basement membrane is remodeled during ischemia/reperfusion 
injury and transmigrated neutrophils are positive for laminin. 
WT and NE-/- mice were subjected to ischemia / reperfusion of their cremaster muscles or 
mesentery as described in the Material and methods. At the end of the reperfusion period, 
tissues were collected, fixed and whole-mount immunostained for neutrophils (MRP14) 
and basement membrane (Laminin-5 or pan-laminin) prior to visualization of the samples 
by confocal microscopy. (A) Representative images showing the presence of low 
expression regions (LERs; circles) within the BM (Laminin-5) of post-capillary venules 
of mouse cremaster muscles. (B) Quantification of the size of the LER within the BM 
(Laminin-5) of the cremaster postcapillary venules. (C) Representative images showing 
the presence and remodeling of LERs (circles) within the BM (Laminin-5) of post-
capillary venules of mouse mesentery. (D) Quantification of the size of the LER within the 
BM (Laminin-5) of the mesenteric postcapillary venules. (E) Representative confocal 
image of a postcapillary venule (from a WT mouse subjected to I/R) showing the presence 
of laminin positive neutrophils within the interstitial tissue (arrows). The bottom picture 
shows the staining of Laminin only. (F) Quantification of the number on neutrophils present 
within the venular basement membrane 1.5 h post reperfusion of the mesentery. Figures 
are representative of 4–7 animals per group. Mean ± SEM. * P<0.05, ** P<0.01, *** 
P<0.001, for comparison between sham and I/R groups; and # P<0.05, ### P<0.001 for 
comparison between WT and NE-/- mice as indicated by the line. Bars = 10 µm. 
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Figure 6. NE-genetic deficiency inhibits neutrophil activation and 
monocyte/macrophage recruitment. 
The cremaster muscles of WT and NE−/− mice were subjected to temporary ischemia 
followed by reperfusion; and leukocyte phenotype and vascular leakage were quantified 
by flow cytometry and Evan’s blue assay, respectively. (A) Quantification of the total 
number of neutrophils in the cremaster muscles (i.e. interstitial and vascular neutrophils 
included). (B) Quantification of ROS generation by isolated neutrophils from blood or 
cremaster muscles as measured by DHE mean fluorescence intensity (MFI). (C) 
Quantification of the vascular leakage into the tissue post-reperfusion (4 h). (D) 
Quantification of total number of monocytes in the cremaster muscles at 20 h post 
reperfusion. (E) Quantification of the total number of M2 (CD206+) macrophages in the 
cremaster muscles at 20 h post reperfusion. Data represent mean ± SEM from 4–6 mice 
per group (from 3 independent experiments). * P<0.05, ** P<0.01, for comparison between 
sham and I/R groups; and # P<0.05, ## P<0.01 for comparison between WT and NE-/- 
mice as indicated by the line.  
39 
 
 
SUPPLEMENTARY MATERIAL ONLINE 
 
Supplementary materials and methods YES, all within the same combined file with 
Suppl Figures 
 
Supplementary figure and movie legends YES, all within the same combined file 
with Suppl Figures 
Figure S1. Assessment of renal dysfunction following kidney ischemia/reperfusion injury 
(I/R injury) 
Figure S2. Assessment of blood neutrophils, vessel diameter and hemodynamics of 
postcapillary venules in WT and NE-/- animals 
 
Figure S3. Pharmacological inhibition of neutrophil elastase blocks the migration of 
neutrophils at the level of the basement membrane post I/R injury 
 
Figure S4. Specificity of a new rabbit anti-mouse NE antibody 
 
Figure S5. Assessment of blood monocytes of WT and NE-/- animals following I/R injury 
 
Movie S1. Bright-field intravital microscopy of the NE-/- cremaster muscle subjected to 
ischemia/reperfusion injury 
 
Movie S2. Bright-field intravital microscopy of the NE-/- cremaster muscle subjected to 
ischemia/reperfusion injury 
 
Movie S3. Bright-field intravital microscopy of the mesenteric tissue subjected to 
ischemia/reperfusion injury 
 
 






Neutrophil elastase plays a non-redundant role in remodeling the venular basement 
membrane and supporting neutrophil diapedesis post ischemia/reperfusion injury. 
 
Voisin et al. J Pathol DOI: 10.1002/path ??? copy ed please add number 
 
 
Contents: 
Supplementary Materials and methods 
Supplementary Figures and legends 
Supplementary Movie legends 
Supplementary Material and Methods 
Reagents/antibodies.  
Tyrode’s salt, FCS, PFA, EDTA, Triton X-100, collagenase IV, DNase I, rabbit purified IgG, 
anti-mouse α-SMA antibody (clone 1A4), PKH26 and Evans blue were all purchased from 
Sigma-Aldrich (Poole, Dorset, UK). Mouse Cytokine and chemokine TNF, IL1, CXCL1 and 
CCL2 ELISA kits were from R&D systems (Abingdon, Oxford, UK). Alexa Fluor monoclonal 
antibody labelling kits and Alexa Fluor fluorescently-labelled secondary antibodies, and 
CountBright™ Absolute Counting Beads were from Invitrogen (Paisley UK). Anti-mouse 
antibodies against CD31 (clone 390), CD11b (Mac-1, cloneM1/70) and CD115 (clone 
AFS98), CD45 (clone 30-F11). Ly6G (clone 1A8), F4/80 (cloneEMR1), CD206 (clone 
MR6F3) and the isotype controls IgG2b and IgG2a were purchased from eBiosciences 
(Hatfield, UK) and/or Biolegend (London, UK). Anti-MRP14 [74] (clone 2B10) was a gift from 
Dr N. Hogg (Cancer Research UK, London, UK). Rabbit anti-mouse NE Ab was generated 
by Eurogentec (Belgium) and specificity of staining was confirmed in both blood and tissue-
infiltrated neutrophils of WT and NE-/- animals (Supplementary material, Figure S4). 
123Ecount beads and dihydroethidium (DHE) was purchased from ThermoFisher (Paisley, 
UK) and NE680FAST was obtained from PerkinElmer (Buckinghamshire, UK). 
 
Animals 
Male C57BL/6 wild-type (WT) mice (Harlan, Bicester, UK) and age matched neutrophil 
elastase knock-out (NE-/-) mice were used. NE-/- mice (backcrossed on C57BL/6 background 
for at least 9 generations) were generated by targeted gene disruption as previously detailed 
[28] and obtained as a gift from Prof S. Shapiro (Harvard Medical School, Boston, MA, USA). 
No differences in neutrophil blood counts, vessel diameter or hemodynamics (i.e. wall shear 
rate) were noted between WT and NE-/- animals (supplementary material, Figure S2). 
Animals were housed in individually ventilated cages and facilities were regularly monitored 
for health status. All animal experiments were conducted in accordance with the United 
Kingdom Home Office legislations and the number of mice per experimental group was kept 
to the minimum to reach statistical significance (with a minimal significance level of 0.05% 
and 80% power) and reproducibility in accordance with NC3R recommendations. 
 
Treatments 
Anaesthetized WT mice were injected via jugular vein cannulation with saline or with 
sivelestat (ONO-5046) (Biotechne, Abingdon, UK) with an initial dose of 50 mg/kg in a 200 μl 
bolus preceding the induction of ischemia followed by an infusion of 50 mg/kg in 200 μl per 
hour during the reperfusion period, as per previous works [56].  
 
Ischemia/reperfusion injury of the heart 
Anaesthetized animals (150 mg/kg ketamine, 7.5 mg/kg xylazine, i.p.) were subjected to a 
tracheotomy for artificial ventilation (Harvard Apparatus, AH 40-1000). The tidal volume of 
the respirator was set at 1 ml/min, with the rate set at 100 strokes/min, and was supplemented 
with 100% oxygen. After completion of the surgical procedures, mice were allowed to stabilize 
for 30 min before the ligation of the left anterior descending coronary artery (LADCA) was 
performed using a 6/0 silk suture (Ethicon, W593 7/0 BV1, Edinburgh, UK). Sham-operated 
animals received the same surgical procedure without completing the full ligation of the 
LADCA. Ischemia was confirmed by the appearance of hypokinesis and pallor distal to the 
occlusion. After a 25 min period of myocardial ischemia, the clip was removed to allow tissue-
reperfusion (visually confirmed) for 2 h. At the end of the experiment, mice were killed; heart 
removed and ‘snap’ frozen with liquid nitrogen before being processed for cryosectioning and 
confocal microscopy analysis. 
 
Ischemia/reperfusion injury of the kidneys 
Mice were anaesthetized for the duration of surgical procedures (Ketamine 125 mg/kg, i.p.). 
Animals were subjected to bilateral renal ischemia for 30 min following abdominal 
laparotomy, during which the renal arteries and veins were occluded using micro-aneurysm 
clamps as previously described [75]. After the removal of renal clamps the incision was 
sutured and mice were allowed to recover from anesthesia for 24 h with analgesia 
(buprenorphine 10 mg/kg s.c.). Sham-operated mice underwent identical surgical procedures 
without the use of micro-aneurysm clamps. At the end of the experiments, mice were humanly 
sacrificed, blood samples were taken for serum analysis and kidneys were collected for 
histological section analysis.  
 
Intravital microscopy and induction of cremasteric ischemia/reperfusion injury 
Intravital microscopy (IVM) was used to directly observe leukocyte responses within mouse 
cremaster venules as previously detailed [32]. In brief, mice were anaesthetized (125 mg/kg 
Ketamine, 12.5 mg/kg, Xylazine, i.p). The cremaster muscle was surgically exteriorized onto 
a purpose-built microscope stage and was kept warm and moist by continuous application of 
warmed Tyrode’s balanced salt solution. Tissue ischaemia was induced by placing an artery 
clamp at the proximal end of the pinned cremaster tissue for 30 min. Reperfusion was initiated 
by releasing the clamp and restoring blood flow for up to 2 h. Leukocyte responses were 
observed on an upright bright-field microscope (Carl Zeiss, Welwyn Garden City, UK). Firmly 
adherent cells were those remaining stationary for 30 s or longer within a given 500 µm 
segment of the endothelial surface of the lumen of postcapillary venules (20–40 µm in 
diameter). Extravasated leukocytes were quantified within 50 µm on either side of the 500 µm 
vessel segment in the perivenular tissue. Red blood cell center-line velocity was measured 
in postcapillary venules with an optical Doppler velocimeter (Microcirculation Research 
Institute, Texas A&M University, Dallas, TX, USA) and venular wall shear rate was 
determined based on the Newtonian definition: wall shear rate = 8000 [(red blood cell 
velocity/1.6)/venular diameter]. At the end of the experiment, mice were humanly killed, tissue 
removed and fixed in 4% paraformaldehyde (PFA) or 100% ice cold-methanol for 30 min for 
immunostaining purposes.  
 
Intravital microscopy and induction of ischemia/reperfusion injury of the mesenteric tissue 
Anesthetized mice (150 mg/kg Ketamine, 7.5 mg/kg Xylazine, i.p.) were placed in supine 
position on a heating pad (37 ºC) for maintenance of body temperature. Mesenteric ischemia 
was induced with a micro-aneurysm clip (Harvard Apparatus), clamping the superior 
mesenteric artery for 35 min. The clip was then removed, and reperfusion allowed for 90 min. 
Sham-operated animals underwent the same surgical procedure except for the clamping of 
the superior mesenteric artery. The mesenteric vascular bed was exteriorized, placed on a 
purpose-built stage of an upright brightfield microscope (Zeiss Axioskop “FS”). Mesenteries 
were superfused with warmed (37 ºC) bicarbonate-buffer solution. A 5-min equilibration 
period preceded the ischemia. Analysis of leukocyte-endothelium interactions was made in 
1 to 3 randomly selected post-capillary venules (20–40 µm in diameter, 100 µm in length) for 
each mouse 90 min post-reperfusion. Leukocyte adhesion (stationary position of the cell for 
30 s or longer) was quantified along a 100 µm vessel length. Leukocyte extravasation 
response was quantified were quantified within 50 µm on either side of the 100 µm vessel 
segment in the peri-venular tissue. Red blood cell center-line velocity was measured in post-
capillary venules with an optical Doppler velocimeter (Microcirculation Research Institute, 
Texas A&M University, Dallas, TX, USA) and venular wall shear rate was determined based 
on the Newtonian definition: wall shear rate = 8000 [(red blood cell velocity/1.6)/venular 
diameter]. At the end of the reperfusion and analysis period, mice were humanly killed, and 
mesenteric tissues removed and fixed in 4% paraformaldehyde (PFA) for 30 min prior to 
immunostaining for observation by confocal fluorescence microscopy. 
 
Determination of renal injury and dysfunction 
Blood samples were collected via cardiac puncture for the mouse into S/1.3 tubes containing 
serum gel (Sarstedt, Germany). The samples were centrifuged (6000 x g for 3 min). Serum 
levels of creatinine and aspartate aminotransferase were quantified by ELISA (R&D systems, 
Abingdon, Oxford, UK). 
 
Histological evaluation of renal injury 
Kidneys were cut in a sagittal section into two halves, fixed in 10% (w/v) PFA at room 
temperature for 1 week. After dehydration using graded ethanol, tissues were embedded in 
Paraplast (Sherwood Medical, Mahwah, NJ) and cut into 8 µm-thick sections mounted on 
glass slides. Sections were then deparaffinized with xylene, stained with hematoxylin and 
eosin, and viewed under a light microscope (Dialux 22, Leitz, Milan, Italy). For the 
histopathological score, 100 intersections were examined for each kidney and a score from 
0 to 3 was given for each tubular profile involving an intersection: 0, normal histology; 1, 
tubular cell swelling, brush border loss, nuclear condensation, with up to one third of the 
tubular profile showing nuclear loss; 2, as for score 1, but greater than one third and less than 
two thirds of tubular profile show nuclear loss; 3, more than two thirds of tubular profile shows 
nuclear loss. The total score for each kidney was calculated by addition of all 100 scores with 
a maximum score of 300. All the histological studies were performed in a blinded fashion [76]. 
The total number of infiltrating leukocytes (e.g., neutrophils and mononuclear cells) in cortical 
interstitial spaces was assessed quantitatively by counting the number of PMNs in high-
power fields using x20 or x40 objectives based on the morphology of the nuclei of 
hematoxylin-eosin stained sections (supplementary material, Figure S1A). 
 
Adoptive cell transfer experiments 
To investigate the behavior specifically of WT or NE-/- neutrophils during their migration 
through the venular wall, adoptive transfer experiments were performed. For this purpose, 
bone marrow leukocytes from WT or NE-/- donor mice were harvested from the femur and 
tibia. Cells were then sieved and counted, re-suspended in PBS and incubated with the 
membrane labelling fluorescent indicator PKH26 according to the manufacturer’s 
recommendations (Sigma) at 37 °C for 30 min. Cells were then injected intravenously into 
WT or NE-/- recipient animals via the tail vein (107 cells/mouse) prior to be subjected I/R injury 
of the cremaster muscles as detailed above. At the end of the reperfusion period, the 
cremaster muscles were exteriorized, fixed and immunostained as detailed below for 
observation by confocal fluorescent microscopy. Blood samples were also taken from cardiac 
puncture and the number of circulating PKH26+ cells was analyzed by flow cytometry. The 
results are shown as the number of transmigrated PKH26 cells in 0.02 mm2 of tissue area 
per % of PHK26+ cells in the blood in order to normalize the results for the number of blood 
recirculating cells following the adoptive transfer. 
 
Analysis of tissues by immunofluorescence labeling and confocal microscopy 
Detection of neutrophils in the ischemic region of the heart was performed on OCT-
embedded heart tissue sections. In brief , sections (30 µm thick) were fixed for 10 min with 
methanol, permeabilized and blocked in PBS supplemented with 10% FCS, 10% GS and 
0.5% Triton X-100 for 1 h and then incubated in PBS + 10% FCS overnight at room 
temperature with a rabbit anti–mouse collagen IV polyclonal Ab, and fluorescently-labeled rat 
anti-mouse CD31 and a rat anti–mouse MRP-14 Ab at a concentration of 10 µg/ml to label 
the endothelium and neutrophils, respectively. Sections were then washed in PBS and 
incubated with Alexa Fluor-488 labelled goat anti-rabbit for 2 h at RT. Tissue sections were 
then visualized using confocal microscopy (Zeiss LSM5 Pascal) using 10x (NA:0.25) or 20x 
(NA:0.50) objectives. Images were subsequently analyzed with IMARIS analysis software 
(Bitplane, Switzerland). To reconstruct the entire heart sections, serial images were taken 
and reassembled using Photoshop CS3. Fluorescence intensity quantification was done 
using IMARIS software using the same settings for all groups. 
Detection of neutrophils into the cremaster muscles and mesenteric tissue following I/R injury 
was performed by immunostaining of whole-mount tissues and visualized by confocal 
microscopy. In brief, PFA-fixed and permeabilized tissues (PBS containing 10% normal goat 
serum, 10% of FCS, 5% of mouse serum and 0.5% Triton X-100 for 2 h at room temperature) 
were immunostained for neutrophils (rat anti-mouse MRP-14 mAb) and the perivascular 
basement membrane (rabbit anti-mouse LNα-5 mAb, gift from Prof Tanaka) in PBS + 10% 
FCS overnight at 4 °C. MRP-14 is an intracellular protein highly abundant in neutrophils that 
is well accepted as a neutrophil specific marker for whole-mount tissues immunostaining and 
confocal microscopy [74, 77]. Following three washes in PBS, tissues were subsequently 
incubated with specific Alexa Fluor-633-conjugated anti-rat or Alexa Fluor 555-conjugated 
anti-rabbit secondary antibodies (Invitrogen) for 4 h at RT in PBS + 10% FCS. In order to 
stain for endothelial cells, tissues were blocked with rat IgGs for 2 h before adding a rat anti-
mouse Alexa Fluor-488-conjugated CD31 mAb. For NE expression, WT and NE-/- tissues 
were first immunostained against neutrophils (rat anti-mouse MRP-14) and rabbit anti-NE 
Abs in PBS + 10% FCS overnight at 4 °C. Following three washes in PBS, tissues were 
subsequently incubated with specific Alexa Fluor-647-conjugated anti-rat- and -555-
conjugated anti-rabbit secondary antibodies for 4 h at RT in PBS + 10% FCS. In order to 
stain for venular basement membrane, tissues were blocked with rabbit IgGs for 2 h before 
being incubated with the rabbit anti-mouse Pan-Laminin Ab directly labeled with Alexa Fluor-
488 according to the antibody labeling Zenon kit protocol. All samples were viewed using a 
Zeiss LSM 5 Pascal laser-scanning confocal microscope (Carl Zeiss Ltd, Welwyn Garden 
City, UK) with a 40× objective (NA:0.75)., All image acquisition parameters for NE expression 
as quantified by immunostaining and confocal microscopy (e.g. laser power, detector gain 
voltage, and image format) were normalized to NE-/- tissues. In some experiments, the 
specificity of staining was also confirmed in WT tissues immunostained with an irrelevant 
rabbit Ig control antibody (not shown). Acquired Z-stack images were used and analyzed for 
3D–reconstruction of whole vessels of 200 μm length (4–6 vessels per tissue) with the image 
processing software IMARIS allowing to accurately visualize the position of leukocytes 
relative to the endothelium and the perivascular basement membrane. Mean fluorescent 
intensity quantification of NE fluorescence was quantified using a mask (isosurface) on the 
MRP14 or Laminin channels using the same settings throughout the analysis. The area and 
intensity of matrix protein “Low expression regions” (LERs) within the perivascular basement 
membrane were measured using ImageJ software (NIH & Laboratory for Optical and 
Computational Instrumentation, University of Wisconsin, USA) as previously detailed [36, 37].  
For the visualization of NE enzymatic activity in vivo, mice were subjected to nonsurgical 
ischaemia using an orthodontic band placed at the top of the scrotums for 35 min followed 
by 1 h of reperfusion. The NE-fluorescent activatable substrate NE680FAST was injected i.v. 
(4.8 nmol per mouse) and a non-blocking Alexa Fluor 555-conjugated rat anti-mouse CD31 
(2 µg/mouse) was injected intrascrotally at the end of the ischemic period. At the end of the 
reperfusion, tissues were harvested, fixed and immunostained with Alexa Fluor 488-
conjugated anti-MRP14 Ab as described above. All samples were then viewed using a Leica 
SP8 laser-scanning confocal microscope with a 20× objective (NA:1) and images of post-
capillary venules (at least 6 vessels per tissue) were acquired with the use of sequential 
scanning of different channels at every 0.5 μm of tissue depth at a resolution of 1024 × 470 
pixels in the x × y plane, respectively. This pixel resolution correspond to a voxel size of 
0.24 × 0.24 × 0.5 μm in x × y × z. All Images were subsequently analyzed off-line with the 3D-
reconstructing image processing software IMARIS (Bitplane, Switzerland). 
The specificity of the anti-NE Ab staining was also assessed in blood neutrophils by 
intracellular immunostaining. In brief, blood leukocytes from WT and NE-/- animals were 
harvested by cardiac puncture, the erythrocytes lysed with ACK buffer solution (150 mM 
NH4Cl, 1 mM KHCO3, 0.1 mM EDTA) and the leukocytes from both genotypes were fixed 
and permeabilized using BD Cytofix/Cytoperm™ kit according to the reagent protocol. Cells 
were then incubated with the solution of staining buffer containing 1% of CD16/CD32 blocking 
reagent and the purified rabbit anti-mouse NE Ab overnight at 4°C. WT or NE-/- cells were 
also incubated with an Alexa Fluor 555-conjugated or Alexa Fluor 647 rat anti-mouse MRP14, 
respectively. Cell were then washed four times prior to incubation with an Alexa Fluor 488-
conjugated goat anti-rabbit secondary antibody for 2 h at 4 °C. After 4 final washes, both WT 
and NE-/- samples were then mounted on the same slides with DAPI-containing mounting 
medium prior to visualization using a Zeiss 800 laser-scanning confocal microscope (Carl 
Zeiss Ltd, Welwyn Garden City, UK) with a 63× objective (NA:1.4). All Images were 
subsequently analyzed off-line with the 3D-reconstructing image processing software 
IMARIS. 
Neutrophil and monocyte phenotypic analysis by flow cytometry 
The cremaster muscles of WT and NE-/- were subjected to 35 min of nonsurgical ischaemia 
using an orthodontic band followed by 20 h of reperfusion. Blood (200 µl per animal) was 
collected by cardiac puncture and the cremaster muscles were harvested and digested into 
single cell suspension with collagenase and DNase I for 30 min at 37 °C. Cells were 
fluorescently labeled with conjugated antibodies against CD45, Ly6G, CD11b, CD115, 
CD206, F4/80 Abs (0.2–2 μg/ml, various fluorochromes) and with FC block for at least 30 min 
at 4 °C. For Reactive oxygen species (ROS) detection, cells where first pre-incubated with 1 
µM of DHE for 15 min at 37 °C prior to the incubation with antibodies. CountBright™ Absolute 
Counting Beads were used to quantify the total number of cells following manufacturer’s 
recommendations. Samples were analyzed using a BD LSR-Fortessa (BD Biosciences) and 
FlowJo analysis software (Treestar, BD Biosciences). Leukocytes were first gated with CD45 
and FCS/SSC morphology (excluding cell doublet). Neutrophils were identified as CD45+ 
CD11b+ Ly6G+, monocytes were identified as CD45+ Ly6G- CD11b+, CD115+, F4/80low; 
and M2 macrophage were identified as CD45+ Ly6G- CD11bhigh, F4/80+, CD206+. 
 
Vascular leakage assay (Evan’s blue Miles Assay) 
Vascular leakage was assessed in the mouse cremaster muscle of WT and NE-/- mice 
following ischemia/reperfusion injury. In brief, cremaster muscles were subjected to 35 min 
of nonsurgical ischaemia using an orthodontic band followed by 2 h of reperfusion. Mice 
where then injected intravenously with 0.5% Evans Blue solution (6 µl/g body weight). Two 
hours later (i.e. 4 h post reperfusion), mice were sacrificed and the cremaster muscles were 
excised and incubated in 100% formamide overnight at 56 °C. The optical density of eluted 
Evans Blue in 50 µl of samples was measured by spectrophotometry at wavelength of 620 
nm. Results are presented as optical density (OD) of Evans Blue leakage [31]. 
 
Statistical analyses 
All data was processed and analyzed using Prism 4 software (GraphPad Inc, San Diego, CA, 
USA). Statistical significance was assessed by parametric (one-way/two-way ANOVA 
followed by Newman-Keuls multiple comparison test) and non-parametric (Kruskal-Wallis 
followed Dunn's multiple comparisons test) tests according to the sample size of the data 
analyzed. Where only two variables were analyzed, an unpaired t-test (Mann-Whitney) was 
used. P < 0.05 taken as significant. Results are given as mean  SEM.  
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Supplementary Figure S1 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S1. Assessment of renal dysfunction following kidney 
ischemia/reperfusion injury (I/R injury). WT and NE-/- mice were subjected to bilateral renal 
ischemia for 30 min followed by a 24 h reperfusion period. (A) H&E staining of kidney sections 
showing the presence of PMNs (yellow arrows) in the interstitium of the kidney of a WT mice 
subjected to I/R injury (x40 objective magnification). Bar = 20 µm. The levels of creatinine (B) 
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and aspartate aminotransferase (C) in mouse plasma were measured as biochemical 
markers of renal dysfunction subsequent to sham-operation (WT) or renal 
ischemia/reperfusion injury (WT and NE-/- animals). Data represent mean ± SEM. *** P<0.001 
(5 mice per group) for comparison between I/R versus sham operated animals; and ## 
P<0.01, ### P<0.001 for comparison between WT and NE-/- mice as indicated by lines. 
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Supplementary Figure S2. Assessment of blood neutrophils, vessel diameter and 
hemodynamics of postcapillary venules in WT and NE-/- animals. The cremaster muscles 
or mesentery of WT and NE-/- Mice were subjected to ischemia/reperfusion (I/R) injury (30 
min/2 h for the cremaster muscles or 35 min/90 min for the mesentery) for analysis of 
leukocyte responses by bright-field intravital microscopy and flow cytometry. (A) Percentage 
of circulating neutrophils (of total leukocyte counts) in the blood of animals subjected to I/R 
of the cremaster muscles (left panel) or mesentery (right panel) and as analyzed by flow 
cytometry. (B) Diameters of post-capillary venules of animals subjected to I/R of the 
cremaster muscles (left panel) or mesentery (right panel) as measured by bright-field 
intravital microscopy (C) Wall shear rate within post-capillary venules of animals subjected to 
I/R of the cremaster muscles (left panel) or mesentery (right panel) as measured by bright-
field intravital microscopy. Data represent means ± SEM per mouse. * P<0.05, ** P<0.01 (at 
least 5 mice per group) for comparison between I/R versus sham operated animals. 
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Supplementary Figure S3. Pharmacological inhibition of neutrophil elastase blocks the 
migration of neutrophils at the level of the basement membrane post I/R injury. 
Leukocyte migration responses in the cremaster muscle of WT mice subjected to I/R injury 
were investigated by intravital and confocal microscopy. To inhibit NE, mice received an 
intravenous bolus injection of the NE-specific inhibitor ONO-5046 (sivelestat) followed by a 
continuous infusion of this inhibitor (50 mg/kg/h) before the induction of ischemia. Control 
animals received saline. Leukocyte adhesion (A) and extravasation (B) responses were 
quantified at regular intervals for 120 min from the start of the reperfusion period. (C) At the 
A Adhesion B Extravasation 
end of the experiment, tissues were harvested, fixed and immunostained with fluorescent 
antibodies against neutrophils (MRP14), endothelial cells (CD31) and the basement 
membrane (Laminin-α5) prior to the visualization of the vessels by confocal microscopy. The 
number of neutrophils present within the venular basement membrane was quantified for 
each group of animals. (D) Quantification of the size of the basement membrane low 
expression regions (LERs) from cremaster postcapillary venules of mice subjected to I/R 
injury and/or treated with the NE inhibitor ONO-5046. Data are from at least 5 mice per group 
and are presented as mean ± SEM. * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001 for 
comparison between I/R versus sham operated animals; and ## P<0.01, #### P<0.0001 for 
comparison between ONO-5046 and saline-treated animals as indicated by lines. 
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Supplementary Figure S4. Specificity of a new rabbit anti-mouse NE antibody. (A) 
Blood leukocytes from WT and NE-/- animals were immunostained for NE with a rabbit anti-
mouse NE antibody (green) and neutrophils and rat anti-mouse MRP14 conjugated with 
Alexa Fluor 555 (blue) or Alexa Fluor 647 (red) fluorochromes for WT or NE-/- cells, 
respectively. The nuclei of the leukocytes were revealed with DAPI staining. The images 
show that WT but not NE-/- neutrophils, exhibit a positive staining for NE in the cytoplasm but 
Neutrophils 
pericytes 
NE 
NE alone NE, DAPI 
MRP14 (WT   neutrophils) 
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not the nucleus of the cell. (B) Cremaster muscles of WT and NE-/- mice subjected to I/R 
injury were harvested, fixed and immunostained for neutrophils (MRP14, blue), pericytes (α-
SMA, green) and neutrophil elastase (red) prior to imaging by confocal microscopy. The 
images are representative of a WT (left panels) or NE-/- (right panels) mouse post-capillary 
venule showing the expression of NE by WT, but not NE-/- neutrophils. A 5% opacity filter on 
the MRP14 and α-SMA channels was applied to better visualize NE expression within 
neutrophils in the bottom images. Images are representative pictures from n=3 independent 
experiments. Bar = 10 µm. 
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Supplementary Figure S5: Assessment of blood monocytes of WT and NE-/- animals 
following I/R injury. The cremaster muscles of WT and NE-/- mice were subjected to 30 min 
of ischemia followed by a 20 h reperfusion period. The graph shows the quantification of the 
percentage of circulating neutrophils (of total leukocyte counts) in the blood of animals 
subjected to I/R of the cremaster muscles (left panel) or mesentery (right panel) and as 
analyzed by flow cytometry. 
Supplementary Movie legends 
 
Movie S1. Bright-field intravital microscopy of the NE-/- cremaster muscle subjected to 
ischemia/reperfusion injury. The movie captures the development of the inflammatory 
response (leukocyte recruitment) of a post-capillary venule from the cremaster muscle of a 
WT mouse subjected to ischemia (30 min) and reperfusion (120 min) injury as recorded by 
bright-field intravital microscopy. Red blood cell velocity was measure with an optical Doppler 
velocimeter (black dots). Quantification of the inflammatory response is shown in Figure 3A. 
 
Movie S2. Bright-field intravital microscopy of the NE-/- cremaster muscle subjected to 
ischemia/reperfusion injury. The movie captures the development of the inflammatory 
response (leukocyte recruitment) of a post-capillary venule from the cremaster muscle of a 
NE-/- mouse subjected to ischemia (30 min) and reperfusion (120 min) injury as recorded by 
bright-field intravital microscopy. Red blood cell velocity was measure with an optical Doppler 
velocimeter (black dots). Quantification of the inflammatory response is shown in Figure 3A. 
 
Movie S3. Bright-field intravital microscopy of the mesenteric tissue subjected to 
ischemia/reperfusion injury. The movie captures the leukocyte inflammatory response of 
post-capillary venules from the mesentery of WT and NE-/- mice at 90 min post reperfusion 
as recorded by bright-field intravital microscopy. Quantification of the inflammatory response 
is shown in Figure 3B. 
 
